Research location
Abington
Pennsylvania, United States
Advertisement
Research activity in Abington
Pennsylvania, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 186 trials and 192 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Abington
186 linked trials · page 2 of 4A Study of Semorinemab in Patients With Moderate Alzheimer's DiseaseNCT03828747 · 2019-01-25 · 1 site observation
COMPLETED
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast CancerNCT04086875 · 2018-11-07 · 1 site observation
UNKNOWN
TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart FailureNCT03296813 · 2018-07-11 · 1 site observation
COMPLETED
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)NCT03444870 · 2018-06-06 · 1 site observation
TERMINATED
Precision Event Monitoring for Patients With Heart Failure Using HeartLogicNCT03579641 · 2018-06-01 · 1 site observation
COMPLETED
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With DocetaxelNCT03419234 · 2018-04-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Investigate CSL112 in Subjects With Acute Coronary SyndromeNCT03473223 · 2018-03-21 · 1 site observation
COMPLETED
Hemodynamic-GUIDEd Management of Heart FailureNCT03387813 · 2018-03-15 · 1 site observation
COMPLETED
Escitalopram for Agitation in Alzheimer's DiseaseNCT03108846 · 2018-01-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung CancerNCT03366766 · 2017-12-20 · 1 site observation
TERMINATED
A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's DiseaseNCT03289143 · 2017-10-04 · 1 site observation
TERMINATED
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF PatientsNCT03066804 · 2017-08-22 · 1 site observation
COMPLETED
Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate CancerNCT03274687 · 2017-07-28 · 1 site observation
COMPLETED
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast CancerNCT03155997 · 2017-07-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter DefibrillatorNCT02787785 · 2017-04-17 · 1 site observation
COMPLETED
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy RegistryNCT03075215 · 2017-04-14 · 1 site observation
COMPLETED
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast SurgeryNCT03188393 · 2017-04-13 · 1 site observation
COMPLETED
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by SurgeryNCT03070886 · 2017-04-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-StudyNCT03037931 · 2017-03-15 · 1 site observation
COMPLETED
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast CancerNCT02954874 · 2017-01-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection FractionNCT02929329 · 2017-01-06 · 1 site observation
COMPLETED
Junctional AV Ablation in CRT-D: JAVA-CRTNCT02946853 · 2016-10-01 · 1 site observation
COMPLETED
Breast Cancer WEight Loss Study (BWEL Study)NCT02750826 · 2016-09-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain MetastasesNCT02595905 · 2016-09-15 · 1 site observation
COMPLETED
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEFNCT02742129 · 2016-08-10 · 1 site observation
COMPLETED
Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung CancerNCT02642042 · 2016-07-18 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease DementiaNCT02791191 · 2016-06-16 · 1 site observation
TERMINATED
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's DiseaseNCT02760602 · 2016-06-01 · 1 site observation
TERMINATED
Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode.NCT02554890 · 2016-04-29 · 1 site observation
COMPLETED
Feasibility Study of the Intravascular Ventricular Assist System (iVAS)NCT02645539 · 2016-04-01 · 1 site observation
UNKNOWN
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung CancerNCT02635009 · 2015-12-22 · 1 site observation
COMPLETED
A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple SclerosisNCT02545868 · 2015-10-27 · 1 site observation
COMPLETED
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant ChemotherapyNCT02445391 · 2015-10-20 · 1 site observation
ACTIVE_NOT_RECRUITING
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)NCT02465060 · 2015-08-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast CancerNCT02488967 · 2015-07-26 · 1 site observation
ACTIVE_NOT_RECRUITING
REGISTRY EVALUATION OF VITAL INFORMATION FOR VADs IN AMBULATORY LIFENCT01369407 · 2015-07-01 · 1 site observation
COMPLETED
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast CancerNCT02311933 · 2015-05-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)NCT02395172 · 2015-03-24 · 1 site observation
COMPLETED
Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum TreatmentsNCT02282020 · 2015-02-06 · 1 site observation
COMPLETED
Genetic Evaluation of Men (GEM)NCT03076242 · 2014-10-23 · 1 site observation
TERMINATED
Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate CancerNCT02141438 · 2014-08-20 · 1 site observation
COMPLETED
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung CancerNCT02186847 · 2014-08-01 · 1 site observation
COMPLETED
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSENCT02142959 · 2014-06-30 · 1 site observation
COMPLETED
OPsumit USers RegistryNCT02126943 · 2014-04-30 · 1 site observation
COMPLETED
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast CancerNCT02032823 · 2014-04-22 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Gantenerumab in Participants With Mild Alzheimer DiseaseNCT02051608 · 2014-03-27 · 1 site observation
COMPLETED
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerNCT01949337 · 2014-01-22 · 1 site observation
UNKNOWN
A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge PatientsNCT02111564 · 2014-01-07 · 1 site observation
COMPLETED
Dimethyl Fumarate (DMF) Observational StudyNCT02047097 · 2013-11-19 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHFNCT01870778 · 2013-10-02 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.